For those of you who would like to take advantage of our Luck O' the Irish SALE but prefer not to make payments online, you are welcome to send us a check or money order in the amount of $114.12 for a 3-year AD-FREE Premium Service Bundle or $190.20 for a 5-year Bundle. Make checks or money orders payable in US funds to "Investor Village" and send to: Investor Village, P.O. Box 2958, Marrero, LA 70073.
As many of you know, we operate on the honor system around here. So, in closing out our Luck O' the Irish SALE, we wanted to advise those of you who plan to pay by check or money order that you can send a PM to Admin informing us of your intention. We will then upgrade your account for 7 days, allowing you to enjoy our ad-free premium service now and giving you a reasonable amount of time to get your payment in.
The following message was updated on 9/29/2022 12:15:59 AM.
RA value adder: RA image quantification significant barrier to entry to competitors
CC
We
continue to make very good progress in automating the image quantification as
well, which will have significant benefit for the commercial product. We have
the letter of intent and continue to work closely with MIM software on the full
agreement for them to be our commercial partner for image quantification of
tilmanocept imaging in RA. Once again, MIM is a leading medical image software
company based in Cleveland with a large footprint in the nuclear medicine
space. They completed a pilot study using data from our trials, demonstrating
that they can develop a fully automated application that can robustly reproduce
our quantitative imaging results using our proprietary algorithm.
This will be important for rollout of a commercial product. The ability to
perform the quantitative reads rapidly and reproducibly and at large scale
through automated means is critical to large-scale use of tilmanocept for
rheumatoid arthritis. Keep in mind that all of this, the imaging analysis
methodology as well as the data upon which it is built, including the normative
database you've heard us discuss before, is not only critical to deriving the
most accurate and sensitive objective read of our images, but it also serves as
a significant barrier to entry to possible competitors in this space. We will
continue to work with MIM to finalize the terms of the partnership, and we'll make
an announcement when done.